United States · Bill · HR
H.R. 7032 (117th)
Increasing Transparency in Generic Drug Applications Act of 2022
Introduced
9 March 2022
Last action
10 March 2022 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Kuster, Ann M. [D-NH-2], Rep. Schrier, Kim [D-WA-8]
Subjects
Healthcare
Source updated
7 April 2025
Summary
Increasing Transparency in Generic Drug Applications Act of 2022 This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 March 2022
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
9 March 2022
Introduced
Introduced in House
Source: IntroReferral
9 March 2022
Introduced
Introduced in House
Source: IntroReferral
10 March 2022
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 9 March 2022 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 9 March 2022
Introduced in House (PDF)
Introduced in House · EN · 9 March 2022
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 9 March 2022
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Kuster, Ann M. [D-NH-2] · D · Sponsor
- Rep. Schrier, Kim [D-WA-8] · D · Cosponsor
- · hsif00 · Standing
Related records
- related to ← Food and Drug Amendments of 2022
- related to ← Increasing Transparency in Generic Drug Applications Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/7032
- Open data entity: https://api.congress.gov/v3/bill/117/hr/7032
- us · 117-hr-7032 · source updated 7 April 2025